Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Recurrent Cholangiocarcinoma"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Axel Schmid, Abbas Agaimy, Nikolaos Vassos, Aristotelis Perrakis, Robert Gruetzmann, Roland S. Croner
Publikováno v:
Visc Med
Background: Neuroma of the biliary tree is extremely rare with no more than 100 cases reported so far. They mostly present with obstructive jaundice and have been commonly described after surgery or abdominal trauma. Although involvement of the extra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1845ace4d75e2e8b995f511eeaff7996
https://doi.org/10.1159/000510486
https://doi.org/10.1159/000510486
Autor:
Yo-ichi Yamashita, Hirohisa Okabe, Katsunori Imai, Shigeki Nakagawa, Akira Chikamoto, Hideo Baba, Yuki Kitano
Publikováno v:
The American Journal of Surgery. 219:175-180
In this study, we reviewed our experiences and previous studies on surgery for recurrent cholangiocarcinoma (CCA).We analyzed outcomes of 117 patients with recurrent CCA between 2000 and 2015. Twenty-one patients (17.9%) underwent surgical resection
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ce5ffaf0fae84e69c201cf7c174dd47
https://doi.org/10.1016/j.amjsurg.2019.02.015
https://doi.org/10.1016/j.amjsurg.2019.02.015
Publikováno v:
Cureus
Hilar cholangiocarcinoma, also known as Klatskin tumor, is the most common type of cholangiocarcinoma. It usually has a lymphatic spread and is rarely associated with an umbilical nodule, also known as Sister Mary Joseph nodule. We report a case of a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::763f06bc3ab1362841f19cd8cbe52af6
https://doi.org/10.7759/cureus.11673
https://doi.org/10.7759/cureus.11673
Autor:
Dheeratama Siripongsatian, Chetsadaporn Promteangtrong, Anchisa Kunawudhi, Chanisa Chotipanich, Peerapon Kiatkittikul
Publikováno v:
Nucl Med Mol Imaging
A patient with intrahepatic cholangiocarcinoma who underwent hepatic resection with completed neoadjuvant chemotherapy presented with increased CEA levels. Previous whole abdominal and chest CT scan revealed no evidence of local recurrence or metasta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84c6ed542d3d94d1f286b6bc758da65f
https://europepmc.org/articles/PMC8517048/
https://europepmc.org/articles/PMC8517048/
Autor:
Karlyn Powell
Publikováno v:
Brazilian Journal of Anesthesiology, Vol 70, Iss 2, Pp 175-177 (2020)
Revista Brasileira de Anestesiologia
Revista Brasileira de Anestesiologia
Background: The Argon Beam Coagulator (ABC) achieves hemostasis but has potential complications in the form of argon gas embolisms. Risk factors for embolisms have been identified and ABC manufacturers have developed guidelines for usage of the devic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4afb064243ee02ab1bea702d9e210ad7
https://doi.org/10.1016/j.bjane.2019.12.003
https://doi.org/10.1016/j.bjane.2019.12.003
Autor:
Yasuhiro Takihata, Yuki Sota, Shigeru Yamada, Hironori Tsujimoto, Junji Yamamoto, Toshimitsu Iwasaki, Ibuki Fujinuma, Eiji Shinto, Koichi Okamoto, Yoshiki Kajiwara, Yoji Kishi, Kazuki Kobayashibayashi, Hideki Ueno, Shigeo Yasuda, Yuka Isozaki, Takazumi Tsunenari, Yoichi Miyata, Takahiro Einama
Publikováno v:
Molecular and Clinical Oncology
Long-term outcomes after surgical resection of bile duct cancer remain unsatisfactory, and survival, particularly after tumor recurrence, is poor. Gemcitabine and cisplatin combination (GC) therapy is the standard first-line treatment; however, secon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f113798c7f6aad29fa6fabd770f2454c
https://doi.org/10.3892/mco.2021.2234
https://doi.org/10.3892/mco.2021.2234
Autor:
Yoshihiro Sakamoto, Yutaka Suzuki
Publikováno v:
Management of Pancreatic Cancer and Cholangiocarcinoma ISBN: 9789811628696
Survival of patients who undergo curative surgical resection for cholangiocarcinoma remains unsatisfactory, with a reported 5-year survival rate of 33%. An effort to obtain clinical evidence to support adjuvant chemotherapy after curative resection f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e4d1dc36d4c1d65e01949a9cc0d51d5
https://doi.org/10.1007/978-981-16-2870-2_12
https://doi.org/10.1007/978-981-16-2870-2_12
Autor:
Satoshi Kuboki, Masaru Miyazaki, Tsukasa Takayashiki, Shigetsugu Takano, Hiroaki Shimizu, Katsunori Furukawa, Hideyuki Yoshitomi, Masayuki Ohtsuka, Atsushi Kato
Publikováno v:
Annals of Gastroenterological Surgery
Although recent advances in imaging diagnosis, surgical techniques, and perioperative management can result in increased resectability and improved surgical outcomes, most resected patients still develop cancer recurrence. If patients develop cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b0c641fcc0ab0cb48d8d3af96cf2824
https://doi.org/10.1002/ags3.12036
https://doi.org/10.1002/ags3.12036
Autor:
Hauke Lang
Publikováno v:
Visc Med
Background: For recurrent cholangiocarcinoma, systemic chemotherapy is the standard of care. Repeated resection is a potential curative treatment, but data are scarce and outcomes are not well defined so far. Summary: In the last decade there has bee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3850daac1bec2f73def7bc28145ac6e
https://pubmed.ncbi.nlm.nih.gov/33718481
https://pubmed.ncbi.nlm.nih.gov/33718481